Cardiomiopatía hipertrófica
Revisado por pares por Dr Doug McKechnie, MRCGPÚltima actualización por Dr Colin Tidy, MRCGPÚltima actualización 20 Ene 2025
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
- Agregar a fuentes preferidas en Google
En la miocardiopatía hipertrófica, el músculo del corazón se engrosa (hipertrofia) en algunas partes del corazón. En un corazón normal, las células musculares son regulares y tienen un patrón. En la miocardiopatía hipertrófica, las células del músculo cardíaco se vuelven irregulares y desordenadas.
De un vistazo
La miocardiopatía hipertrófica (MCH) provoca que el músculo cardíaco, típicamente alrededor del ventrículo izquierdo, se engrose.
La mayoría de las personas con MCH no tienen síntomas; otros pueden experimentar dificultad para respirar, dolor en el pecho o palpitaciones.
La MCH es a menudo una condición hereditaria, que afecta a aproximadamente 1 de cada 500 personas.
Los familiares cercanos de alguien con MCH deben ser evaluados con un ECG y un ecocardiograma.
El tratamiento tiene como objetivo aliviar los síntomas y prevenir complicaciones, incluyendo cambios en el estilo de vida, medicación o cirugía.
What is hypertrophic cardiomyopathy?
Hypertrophic cardiomyopathy is a disease in which the heart muscle becomes thickened. The muscle surrounding the left ventricle is the area commonly affected. Sometimes the muscle around the right ventricle is also affected.
The degree of thickening may vary in different places. For example, the wall dividing the right and left ventricle (the septum) is often the area with the greatest thickening. In about 1 in 4 people the muscle thickening is evenly distributed throughout the walls of the left ventricle.
A normal heart

Symptoms of hypertrophic cardiomyopathy
Most people with this condition do not have any symptoms. Symptoms can range from mild to severe and may not develop straightaway. Possible symptoms include the following:
Falta de aliento. This may develop only when you exercise if the condition is mild. When the condition is more severe, you can be breathless at rest.
Chest pain (angina). This may develop only when you exercise but it can also occur at rest when it is more severe. The pain occurs because the supply of blood and oxygen to the heart muscle is not sufficient to meet the demands of the thickened muscle.
Palpitaciones. Sometimes abnormalities of heart rhythm (arrhythmias) develop which can cause palpitations. You may become aware that your heartbeat is fast and/or irregular.
Dizziness and fainting attacks. These occur more commonly when you exercise but they may occur when you are resting. This may be due to reduced output of blood from the heart or because of arrhythmias.
Causes of hypertrophic cardiomyopathy
Heart muscle can thicken because of something, such as high blood pressure. In HCM the heart muscle thickens without an obvious cause.
Genética
In most cases the condition is inherited. If a couple (where one person has HCM) has a child, there is a 1 in 2 chance of the child being affected. This pattern of inheritance is called autosomal dominant. It seems that affected people inherit defective genes which are involved in making parts of the heart muscle cells.
How common is hypertrophic cardiomyopathy?
HCM affects about 1 in 500 people. It is sometimes present at birth and can develop in young children. However, it most commonly develops in early adulthood. HCM tends to affect men more often than women.
How does hypertrophic cardiomyopathy progress?
The thickening of the heart muscle does not tend to progress once you stop growing. This means that, for many people, the symptoms remain stable during adulthood.
Unfortunately, the symptoms gradually become worse for some people as the heart muscle becomes more stiff. Sometimes the function of the heart gradually deteriorates and heart failure may develop. See the separate leaflet called Congestive heart failure.
Complications of hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) may lead to problems which include the following:
The affected heart muscle (usually around the left ventricle) may become stiff. This can mean that your left ventricle may not fill as easily as normal. Less blood than normal is then pumped out from your heart with each heartbeat.
The thickening may partly obstruct the flow of blood from your left ventricle into your aorta. This results in less blood being pumped out from your heart. The partial obstruction may also make the blood flow turbulent. Turbulent blood flow can make small blood clots more likely.
The thickened heart muscle may affect the function of your heart valves. In particular, the mitral valve may become leaky if it does not close properly.
In some people, the abnormal heart muscle affects the electrical conducting system of the heart. This may cause abnormal heart rates and/or rhythms to develop.
Sudden collapse and death occurs in a small number of people with HCM. This is probably due to a severe arrhythmia which may develop suddenly.
How is hypertrophic cardiomyopathy diagnosed?
A doctor may suspect this condition because of:
Your symptoms.
Your family history.
Changes on your trazado del corazón (electrocardiograma, o ECG) - this is a tracing of the electrical activity of the heart.
Changes on your chest radiografía. This may show your heart is large or that there is fluid in your lungs.
Un ultrasound scan of the heart (echocardiogram, or 'echo'). This is a painless test which can measure the thickness of your heart muscle.
Cateterismo cardíaco - a small plastic tube is passed into the heart, usually through a blood vessel in the groin, to measure the pressure in the heart chambers.
Once the diagnosis is confirmed, other tests may be needed to assess the severity of your condition. A Doppler ultrasound scan also looks at blood flow through the heart chambers. This shows how well the heart ventricles are filling and contracting. A Doppler ultrasound scan can also show if there is any turbulent blood flow within the ventricles.
Family screening
Your first-degree relatives (mother, father, brother, sister, child) should have tests such as an ECG and an echocardiogram. Some people with HCM do not have any symptoms. This is why close relatives should be screened.
In some centres it may be possible to have a genetic blood test. The children of affected parents should be screened every three years until puberty, and then every year until they reach the age of 20 years.
There is currently no UK national screening policy so the tests available may depend on the services offered at your local hospital.
Treatment for hypertrophic cardiomyopathy
There is no treatment which can reverse the changes of the heart muscle. Treatment aims to ease symptoms if they occur and to prevent complications. If you do not have any symptoms or you only have mild symptoms then you may not need any treatment.
Treatment which may be required includes the following:
General lifestyle advice
Ejercicio. Depending on the severity of the condition, some people are advised not to take part in strenuous sports or jobs. Your doctor can advise you about this.
Peso. Try not to become overweight, which can put an extra strain on your heart.
Alcohol. Normal social drinking in moderation should not affect your heart. However, too much alcohol can affect the heart muscle and should be avoided.
Don't smoke. Fumar can cause more damage to your heart.
Medicamento
The medicines advised depend on what symptoms or complications develop. For example:
Betabloqueantes (such as propranolol) and calcium channel blockers (antagonists) (especially verapamilo) are the commonly used medicines. These can slow the heart rate and make the heart squeeze (contract) less forcefully. This allows more time for the ventricle to fill with each heartbeat. These medicines may be used to treat chest pain, breathlessness and palpitations.
Various other medicines called anti-arrhythmic medicines (por ejemplo, amiodarona) are used to treat and to prevent abnormalities of heart rhythm (arrhythmias). They work by interfering with and helping to correct the electrical impulses in your heart.
An anticoagulant medicine may be advised if you develop fibrilación auricular (a common arrhythmia). With this arrhythmia a blood clot is a possible complication. Anticoagulant medicines help to prevent blood clotting by thinning the blood.
NICE have recommended the use of a drug called mavacamten for certain people with a varying degree of heart failure. It can only be used in addition to already having the right doses of the first choice medication. This medicine has been shown to avoid or delay the need for surgery. See 'Further Reading' below for further information.
Cirugía
If your cardiomyopathy is severe, an operation may be an option:
Septal myectomy. This is an operation to remove a segment of thickened muscle from the wall dividing the right and left ventricle (the septum). It is done as open heart surgery. It is not a cure but it can help when the thick septum is causing obstruction to the flow of blood through the aortic valve.
Alcohol septal ablation. Alcohol is injected into the small blood vessels (arteries) which supply the thickened area of heart muscle. This destroys that part of muscle, which then becomes thinner.
Valve replacement may be needed if the mitral valve is affected and does not work properly.
Implantable cardioverter defibrillator (ICD). Sudden death is a possible complication for people with severe hypertrophic cardiomyopathy. Inserting an implantable cardioverter defibrillator (ICD) has been shown to be effective in reducing the risk of sudden death for people with severe hypertrophic cardiomyopathy.
A heart transplant may be needed in a very small number of people.
¿Cuál es la perspectiva?
The thickening of the heart muscle does not tend to progress once you stop growing. This means that, for many people, the symptoms remain stable during adulthood.
Unfortunately, the symptoms gradually become worse for some people as the heart muscle stiffens. Sometimes the function of the heart gradually deteriorates and heart failure may develop. See the separate leaflet called Congestive heart failure for more details.
Selecciones del paciente para Enfermedad del corazón

Salud del corazón y vasos sanguíneos
Angina microvascular
No existe una definición aceptada para CSX. La causa subyacente puede ser un estrechamiento repentino (espasmo) de las arterias coronarias normales sin evidencia de placas grasas ateromatosas.
por la Dra. Hayley Willacy, FRCGP

Salud del corazón y vasos sanguíneos
Enfermedad de las válvulas cardíacas
Las válvulas cardíacas se encuentran entre las cámaras del corazón y controlan el flujo de sangre a través del corazón. Hay cuatro tipos comunes de problemas en las válvulas del corazón: estenosis mitral, insuficiencia mitral, estenosis aórtica e insuficiencia aórtica. La sección llamada Anatomía del corazón incluye detalles sobre la función del corazón y cómo late.
por la Dra. Philippa Vincent, MRCGP
Preguntas frecuentes
¿Se puede revertir la miocardiopatía hipertrófica (HCM)?
No, actualmente no existe un tratamiento que pueda revertir los cambios en el músculo cardíaco causados por la miocardiopatía hipertrófica. Los tratamientos se centran en aliviar los síntomas y prevenir complicaciones. Si no tienes síntomas o solo son leves, es posible que no requieras ningún tratamiento.
¿Es posible que la condición cardíaca en la miocardiopatía hipertrófica empeore con el tiempo?
Para muchas personas, los síntomas de la miocardiopatía hipertrófica permanecen estables durante la adultez porque el engrosamiento del músculo cardíaco no tiende a progresar una vez que el crecimiento se detiene. Sin embargo, para algunos individuos, los síntomas pueden empeorar gradualmente a medida que el músculo cardíaco se vuelve más rígido, lo que podría llevar a una insuficiencia cardíaca.
¿Por qué algunas personas con miocardiopatía hipertrófica experimentan un colapso repentino o incluso la muerte?
Un pequeño número de personas con miocardiopatía hipertrófica puede experimentar un colapso repentino y muerte. Esto probablemente se deba a una arritmia severa (ritmo cardíaco anormal) que puede desarrollarse de repente. Un desfibrilador cardioversor implantable (DCI) puede usarse para reducir este riesgo en casos severos.
Lecturas adicionales y referencias
- Ommen SR, Mital S, Burke MA, et al; 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
- Firth J; Cardiology: hypertrophic cardiomyopathy. Clin Med (Lond). 2019 Jan;19(1):61-63. doi: 10.7861/clinmedicine.19-1-61.
- Litt MJ, Ali A, Reza N; Familial Hypertrophic Cardiomyopathy: Diagnosis and Management. Vasc Health Risk Manag. 2023 Apr 6;19:211-221. doi: 10.2147/VHRM.S365001. eCollection 2023.
- Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy; NICE Technology appraisal guidance, September 2023
- Raj MA. Hypertrophic Obstructive Cardiomyopathy. StatPearls Publishing, 2023.
- Profilaxis contra la endocarditis infecciosa: Profilaxis antimicrobiana contra la endocarditis infecciosa en adultos y niños que se someten a procedimientos intervencionistas; Guía Clínica NICE (marzo 2008 - última actualización julio 2016)
Sobre el autorVer biografía completa

Dr Colin Tidy, MRCGP
Médico General, Autor Médico
MBBS, MRCGP, MRCP (Paediatrics), DCH
El Dr. Colin Tidy es un médico del NHS, con sede en Oxfordshire.
Acerca del revisorVer biografía completa

Dr Doug McKechnie, MRCGP
Redactor Médico
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
El Dr. Doug McKechnie es un médico de cabecera del NHS que trabaja en Londres. Trabaja a tiempo completo en la práctica clínica y también es el Subdirector del módulo de Práctica Clínica y Profesional en la Escuela de Medicina del University College London.
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
Artículo también disponible en Inglés, Alemán, Español, Francés, Italiano, Portugués, Hindi, Hebreo, Árabe, y Sueco.
Próxima revisión: 19 Ene 2028
20 Ene 2025 | Última versión

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.